ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response. (Q52963656)

9 May 2018

title

ACE2 and Ang-(1-7) protect endothelial cell function and prevent early atherosclerosis by inhibiting inflammatory response. (English)

1 reference

9 May 2018

1 reference

Yue-Hui Zhang

1

1 reference

9 May 2018

Yong-huan Zhang

2

1 reference

9 May 2018

Xue-Fei Dong

3

1 reference

9 May 2018

Qing-Qing Hao

4

1 reference

9 May 2018

Xiao-Ming Zhou

5

1 reference

9 May 2018

Qing-Tao Yu

6

1 reference

9 May 2018

Shu-Ying Li

7

1 reference

9 May 2018

Xu Chen

8

1 reference

9 May 2018

Abdulai Fallah Tengbeh

9

1 reference

9 May 2018

Bo Dong

10

1 reference

9 May 2018

Yun Zhang

11

1 reference

9 May 2018

publication date

27 February 2015

1 reference

9 May 2018

published in

Inflammation Research

1 reference

9 May 2018

volume

64

1 reference

9 May 2018

issue

3-4

1 reference

9 May 2018

page(s)

253-260

1 reference

9 May 2018

Angiotensin converting enzyme 2 and atherosclerosis

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Prevention and endothelial therapy of coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

The intracellular renin-angiotensin system: a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) by 15-lipoxygenase-modified LDL in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Epigallocatechin-3-O-gallate inhibits the angiotensin II-induced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin-(1–7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: Role of MMPs/TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

ACE2 improves right ventricular function in a pressure overload model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00011-015-0805-1

Angiotensin 1-7 promotes cardiac angiogenesis following infarction.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25721616

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25721616

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25721616

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00011-015-0805-1

1 reference

9 May 2018

1 reference

9 May 2018